Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
Ankoor H. Patel; Gaurav N. Pathak; Alexander Chen; Patricia Greenberg; Natale Mazzaferro; Anish Patel; Naveen Mallangada; Carlos D. Minacapelli; Kaitlyn Catalano; Hansel Suthar; Vinod K. Rustgi;
10.1016/j.aohep.2024.101510
Liver steatosis and fibrosis markers¿ association with cardiovascular and renal damage in Japanese adults: the TMM BirThree cohort study
Toshiya Machida; Taku Obara; Mami Ishikuro; Keiko Murakami; Fumihiko Ueno; Aoi Noda; Tomomi Onuma; Fumiko Matsuzaki; Jun Inoue; Shinichi Kuriyama; Nariyasu Mano;
Ann Hepatol. 2023;28:
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study
Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28: